Article citationsMore >>

Ji N, Zhang M, Ren L, Wang Y, Hu B, Xiang J, Gong Y, Wu C, Qu G, Ding W, Yin Z, Li S, Wang Z, Zhou L, Chen X, Ma Y, Tang J, Liu Y, Liu L, Huang M. SARS- CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerg Microbes Infect. 2022 Dec; 11(1): 1115-1125.

has been cited by the following article:

Article

Transient Decrease of Insulin Secretion after COVID-19 Infection in a Patient with Hyperosmolar Hyperglycemic Syndrome

1Department of Acute Critical Care Medicine, Juntendo Shizuoka Hospital, Izunokuni, Japan


American Journal of Medical Case Reports. 2023, Vol. 11 No. 2, 37-40
DOI: 10.12691/ajmcr-11-2-8
Copyright © 2023 Science and Education Publishing

Cite this paper:
Ken-ichi Muramatsu, Ikuto Takeuchi, Soichiro Ota, Youichi Yanagawa. Transient Decrease of Insulin Secretion after COVID-19 Infection in a Patient with Hyperosmolar Hyperglycemic Syndrome. American Journal of Medical Case Reports. 2023; 11(2):37-40. doi: 10.12691/ajmcr-11-2-8.

Correspondence to: Youichi  Yanagawa, Department of Acute Critical Care Medicine, Juntendo Shizuoka Hospital, Izunokuni, Japan. Email: yyanaga@juntendo.ac.jp

Abstract

A 52-year-old male was transported to a local medical facility due to unconsciousness and involuntary movement. His past history included only hypertension. He consumed over 2 L of soft drink per day. His body mass index was 34. As he had hyperosmolar hyperglycemic syndrome and COVID-19 infection, he was transferred to our department. On arrival, he was in a coma and pre-shock state. He was therefore intubated. Initially, his blood C-peptide level was low, and he showed hyperglycemia with ketosis. Whole body computed tomography (CT) showed pneumonia. He was diagnosed with hyperosmolar hyperglycemic syndrome with ketosis, COVID-19 infection, convulsion, hemoconcentration, liver dysfunction, rhabdomyolysis, pancreatitis, renal failure and hypernatremia. He was admitted to the intensive care unit, where he was successfully treated. His blood C-peptide returned to the normal range (2.2 ng/mL) on day 20, and he returned to the local medical facility on day 21. This is the first report of transient decrease in insulin secretion after COVID-19 infection in a patient with a combination hyperosmolar hyperglycemic syndrome and ketosis. Further prospective studies are needed to clarify the characteristics of the insulin secretion function following COVID-19 infection.

Keywords